Cardiac Adverse Events Related to Immune Checkpoint Inhibitors

JACC Case Rep. 2020 Feb 19;2(2):200-202. doi: 10.1016/j.jaccas.2019.12.028. eCollection 2020 Feb.

Dorothy M Gujral^{1

2}, Elie N Mouhayar³, Sanjeev Bhattacharyya^{4

5

6}

¹ Department of Clinical Oncology, Imperial College Healthcare NHS Trust, London, United Kingdom.
² Department of Surgery & Cancer, Imperial College, London, United Kingdom.
³ Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁴ Echocardiography Laboratory, St. Bartholomew's Hospital, London, United Kingdom.
⁵ William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
⁶ Institute of Cardiovascular Sciences, UCL, London, United Kingdom.

No abstract available

Keywords: cancer; cardiac events; immune checkpoint inhibitors.

Publication types